レンチウイルスベクターの世界市場 – 2030 年までの業界動向と予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Healthcare レンチウイルスベクターの世界市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

レンチウイルスベクターの世界市場 – 2030 年までの業界動向と予測

  • Healthcare
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 ページ
  • テーブル数: 220
  • 図の数: 60
Buy Now 今すぐ購入

レンチウイルスベクターの世界市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
 2023 –2030
Diagram 市場規模（基準年）
 USD 10.30 Million
Diagram Market Size (Forecast Year)
 USD 25.32 Million
Diagram CAGR
 %
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>レンチウイルスベクターの世界市場、コンポーネント別（レンチウイルスプロモーター、レンチウイルス融合タグ、レンチウイルスパッケージングシステムなど）、タイプ別（製品とサービス）、世代別（第4世代、第3世代、第2世代、第1世代）、ワークフロー別（上流処理と下流処理）、送達方法別（生体内および生体外）、疾患適応症別（がん、遺伝性疾患、感染症、獣医疾患など）、用途別（遺伝子治療とワクチン学）、エンドユーザー別（バイオテクノロジー企業、製薬会社、研究業務受託機関、受託開発製造組織（CDMO）、学術研究機関）– 2030年までの業界動向と予測。

レンチウイルスベクター市場

 レンチウイルスベクター市場の分析と規模

新型コロナウイルス感染症の流行中、高齢人口の増加とワクチン開発の需要がレンチウイルスベクター市場の成長を効果的に促進しています。主要な市場プレーヤーによる戦略的取り組みやゲノミクスへの資金提供の増加により、レンチウイルスベクター市場の成長の機会が生まれています。

Data Bridge Market Research の分析によると、レンチウイルスベクター市場は 2022 年に 1,030 万ドルで、2023 年から 2030 年の予測期間中に 11.9% の CAGR で成長し、2030 年には 2,532 万ドルに達すると予想されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Research がまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

レンチウイルスベクター市場の範囲とセグメンテーション  

レポートメトリック

詳細

予測期間

2023年から2030年

基準年

2022

歴史的な年

2021 (2015 - 2020 にカスタマイズ可能)

定量単位

売上高（百万米ドル）、販売数量（個数）、価格（米ドル）

対象セグメント

コンポーネント (レンチウイルスプロモーター、レンチウイルス融合タグ、レンチウイルスパッケージングシステムなど)、タイプ (製品とサービス)、世代 (第 4 世代、第 3 世代、第 2 世代、第 1 世代)、ワークフロー (上流処理と下流処理)、配信方法 (生体内および生体外)、疾患の適応症 (がん、遺伝性疾患、感染症、獣医疾患など)、用途 (遺伝子治療とワクチン学)、エンドユーザー (バイオテクノロジー企業、製薬企業、研究業務受託機関、受託開発製造組織 (CDMO)、学術研究機関)

対象国

北米では米国、カナダ、メキシコ、ヨーロッパではドイツ、フランス、英国、オランダ、スイス、ベルギー、ロシア、イタリア、スペイン、トルコ、ヨーロッパではその他のヨーロッパ、中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、アジア太平洋地域 (APAC) ではその他のアジア太平洋地域 (APAC)、中東およびアフリカ (MEA) の一部としてのサウジアラビア、UAE、南アフリカ、エジプト、イスラエル、中東およびアフリカ (MEA) の一部としてのその他の中東およびアフリカ (MEA)、南米の一部としてのブラジル、アルゼンチン、南米のその他の地域

対象となる市場プレーヤー

Cobra Biologics Limited（英国）、Sirion-Biotech GmbH（ドイツ）、Merck KGaA（ドイツ）、FinVector Oy（フィンランド）、Oxford Biomedica（英国）、OriGene Technologies, Inc.（米国）、Sino Biological Inc.（中国）、Cell Biolabs, Inc.（米国）、Batavia Biosciences BV（オランダ）、Lonza（スイス）、GENEMEDI（中国）、Takara Bio Inc.（日本）、Thermo Fisher Scientific Inc.（米国）、Waisman Biomanufacturing（米国）、Cytiva（米国）

市場機会
  • がん治療のためのT細胞工学におけるレンチウイルスベクターの需要が急増

市場の定義

レンチウイルスベクター (LV) は、非分裂細胞と分裂細胞の両方で目的の遺伝子を安定的に発現できるため、哺乳類細胞での遺伝子導入に効果的な媒体です。レンチウイルスは、潜伏期間が長く、感染が持続するヒトおよび動物の病原体です。最初の感染から最初の症状が現れるまでの期間は、数か月から数年かかることがあります。分子生物学者は、遺伝物質を細胞に送達するためにウイルスベクターを頻繁に使用します。この手順は、生体内 (生体内) または細胞培養 (試験管内) で実行できます。ウイルスは、感染した細胞内でゲノムを効率的に輸送するための特殊な分子メカニズムを進化させてきました。

レンチウイルスベクター市場の動向

ドライバー

  • 研究開発活動の強化

さまざまなメーカーが新しいレンチウイルス遺伝子治療の研究開発を行っており、これが世界のレンチウイルスベクター市場の成長を牽引すると期待されています。たとえば、臨床段階の遺伝子治療会社であるAVROBIO, Inc.は、2020年5月14日にポンペ病に対するAVR-RD-03の前臨床データを発表しました。この研究では、筋肉と中枢神経系（CNS）におけるポンペ病の症状に対するレンチウイルス遺伝子治療の有効性が実証されました。

  • 合意と協力の増加

レンチウイルスベクター市場は、主要企業が契約やコラボレーションなどのさまざまな無機成長戦略に注力しているため、成長すると予想されています。たとえば、bluebird bio, Inc. は、2017 年 5 月に Novartis Pharma AG とライセンス契約を締結しました。Novartis は、腫瘍治療の開発と商品化のために、レンチウイルスベクター技術に関連する特定の bluebird 特許権を非独占的にライセンスします。

機会

  • がん治療のためのT細胞工学におけるレンチウイルスベクターの需要が急増

レンチウイルスベクターは、遺伝子改変細胞ベースの療法、特にT細胞療法の形成にすでに役立っています。このようなベクターは、抗がん免疫を誘導するために成熟T細胞にキメラ抗原受容体（CAR）またはクローンT細胞受容体を送達するためにも使用されます。レンチウイルスベクターを使用して生成されたCAR T細胞療法がB細胞悪性腫瘍の患者に顕著な臨床効果を示した後、FDAはレンチウイルスベクターを使用した最初の遺伝子操作細胞療法を承認しました。レンチウイルスベクターはCAR T細胞療法とともに変化し進化しており、現在では代替療法として、またより広範な癌の治療における強力な補助ツールとしてその可能性を最大限に発揮しています。

制約/挑戦

  • スケーラビリティと下流の精製の欠如

レンチウイルスベクターの拡張性の欠如と下流精製の制限は、レンチウイルスベクター市場の将来の成長を妨げる可能性があります。主要な市場プレーヤーによる戦略的イニシアチブとゲノミクスへの資金の増加は、世界のレンチウイルスベクター市場が成長するチャンスを提供します。レンチウイルスベクター製品に関連する厳格な規制ポリシーと副作用は、将来の市場成長に対する課題となります。

このレンチウイルスベクター市場レポートでは、最近の新しい開発、貿易規制、輸出入分析、生産分析、バリューチェーンの最適化、市場シェア、国内および現地の市場プレーヤーの影響、新たな収益源の観点から見た機会の分析、市場規制の変更、戦略的市場成長分析、市場規模、カテゴリ市場成長、アプリケーションのニッチと優位性、製品承認、製品発売、地理的拡大、市場における技術革新などの詳細が提供されます。レンチウイルスベクター市場に関する詳細情報を取得するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが、市場成長を達成するための情報に基づいた市場決定を行うお手伝いをいたします。

COVID-19 レンチウイルスベクター市場への影響

2020年3月、米国食品医薬品局（FDA）は、COVID-19公衆衛生上の緊急事態中に医薬品の臨床試験を実施するためのガイドラインを発行しました。2020年7月2日、ガイドラインは再度更新されました。FDAガイドラインには、COVID-19公衆衛生上の緊急事態中に、治験依頼者と研究者が治験参加者の安全を確保し、適正臨床試験基準（GCP）を遵守し、治験の完全性のリスクを最小限に抑えるのに役立つ一般的な考慮事項が含まれています。ガイドラインの付録には、FDAがさまざまな依頼者と研究者から受け取った、COVID-19公衆衛生上の緊急事態中の臨床試験の実施に関する一般的な質問への回答も記載されています。

最近の動向

  • 2020年、ワイスマン・バイオマニュファクチャリングは、カリフォルニアに拠点を置くバイオテクノロジー企業ギガジェンと戦略的提携を結び、COVID-19の治療と予防のための新薬を開発しました。同社が結んだこの戦略的提携により、ワイスマン・バイオマニュファクチャリングによる新種の医薬品の開発と試験の利用が増え、同社のサービスに対する市場認知度が高まることになります。
  • 2021年、オックスフォード・バイオメディカはベーリンガーインゲルハイムとウイルスベクターの製造と供給に関する新たな3年間の開発・供給契約を締結しました。この契約により、今後数年間で同社の売上成長が促進されると期待されています。

レンチウイルスベクターの世界市場規模

レンチウイルスベクター市場は、コンポーネント、タイプ、世代、ワークフロー、配信方法、疾患の兆候、アプリケーション、およびエンドユーザーに基づいてセグメント化されています。これらのセグメント間の成長は、業界のわずかな成長セグメントを分析するのに役立ち、ユーザーに貴重な市場の概要と市場の洞察を提供し、コア市場のアプリケーションを特定するための戦略的決定を下すのに役立ちます。

成分

  • レンチウイルスプロモーター
  • レンチウイルス融合タグ
  • レンチウイルスパッケージングシステム
  • 他の

 タイプ

  • 製品
  • サービス

 世代

  • 第4世代
  • 第3世代
  • 第2世代
  • 第1世代

配送方法

  • 生体内
  • 生体外

病気の兆候

  • 癌
  • 遺伝性疾患
  • 感染症
  • 獣医疾患
  • 他の

 応用

 エンドユーザー

  • バイオテクノロジー企業
  • 製薬会社
  • 契約研究機関 契約開発
  • 製造組織（CDMO）
  • 学術研究機関

ワークフロー  

  • 上流
  • プラスミド製造
  • 細胞増殖
  • プラスミドトランスフェクションとウイルスベクターの生産
  • 下流
  • 精製
  • 充填して仕上げる

レンチウイルスベクター市場の地域分析/洞察

レンチウイルスベクター市場が分析され、市場規模の洞察と傾向が、上記のように国、コンポーネント、タイプ、世代、ワークフロー、配信方法、疾患の兆候、アプリケーション、およびエンドユーザー別に提供されます。

レンチウイルスベクター市場レポートでカバーされている国は、北米では米国、カナダ、メキシコ、ヨーロッパではドイツ、フランス、英国、オランダ、スイス、ベルギー、ロシア、イタリア、スペイン、トルコ、その他のヨーロッパ諸国、アジア太平洋地域 (APAC) では中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、その他のアジア太平洋地域 (APAC)、中東およびアフリカ (MEA) の一部としてサウジアラビア、UAE、南アフリカ、エジプト、イスラエル、その他の中東およびアフリカ (MEA)、南米の一部としてブラジル、アルゼンチン、その他の南米です。

レンチウイルスベクター市場は、主要な市場プレーヤーの存在と同地域の技術進歩の加速により、北米が優位を占めています。

アジア太平洋地域は、膀胱がん、食道がん、肝臓がん、膵臓がんなどの発生率の増加、米国全土における大手メーカーの存在感の高さ、さらに技術の進歩と外国投資の増加により、2023年から2030年の予測期間に最高の成長率で成長すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、各国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、国内関税と貿易ルートの影響も考慮されます。

ヘルスケアインフラの成長 導入基盤と新技術の浸透

レンチウイルスベクター市場では、各国の医療設備支出の増加、レンチウイルスベクター市場向け各種製品のインストールベース、ライフライン曲線を使用した技術の影響、医療規制シナリオの変化とレンチウイルスベクター市場への影響など、詳細な市場分析も提供しています。データは、2011年から2021年までの履歴期間について利用可能です。

競争環境とレンチウイルスベクター市場シェア分析

レンチウイルスベクター市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、生み出される収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータポイントは、レンチウイルスベクター市場に関連する会社の焦点にのみ関連しています。

レンチウイルスベクター市場で活動している主要企業は次のとおりです。

  • コブラバイオロジクスリミテッド（英国）
  • シリオンバイオテック社（ドイツ）
  • メルクKGaA（ドイツ）
  • FinVector Oy（フィンランド）
  • オックスフォードバイオメディカ（英国）
  • オリジーンテクノロジーズ社（米国）
  • シノバイオロジカル社（中国）
  • セルバイオラボ社（米国）
  • Batavia Biosciences BV（オランダ）
  • ロンザ（スイス）
  • ジェネメディ（中国）
  • タカラバイオ株式会社（日本）
  • サーモフィッシャーサイエンティフィック株式会社（米国）
  • ワイスマンバイオマニュファクチャリング（米国）
  • Cytiva（米国）

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL lentiviral vector market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. component LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET application COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insiGHTS
    1. Adherent and Suspension cultures: OVERVIEW
    2. Pricing of Lentiviral Vectors: Product and Service
      1. Product
      2. Services
  5. global lentiviral vector market: regulatORY FRAMEWORK
    1. REGULATION IN THE UNITED STATES
    2. REGULATIONS IN EUROPE
    3. REGULATIONS IN INDIA
    4. REGULATIONS IN JAPAN
  6. Market Overview
    1. drivers
      1. RisE IN demand for viral vectors
      2. Emergence of COVID-19 and demand for vaccine development
      3. Benefits of Viral vectors for gene therapy
      4. RISE IN NUMBER OF INFECTIOUS DISEASES
      5. GROWING GERIATRIC POPULATION
    2. Restraints
      1. lack of scalability
      2. Limitations of downstream purification
      3. SHORTAGE OF SKILLED PERSONNELS
    3. OPPORTUNITIES
      1. Increased healthcare facility and funding for genomics
      2. RISE IN technological advancement
      3. IncreasE IN demand FOR personalized medicines
      4. Strategic Initiatives by Key market players
    4. CHALLENGEs
      1. stringent government approval policies
      2. Side-effects associated with lentiviral vectors integration
  7. IMPACT OF COVID-19 ON THE Global Lentiviral vector Market
    1. impact on price
    2. impact on demand
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS of Government and MANUFACTURERS
    5. CONCLUSION
  8. Global lentiviral vecTor market, By COMPONENT
    1. overview
    2. lentivirus packaging systems
    3. lentiviral promoter
      1. lentivirus promoter vectors
      2. lentivirus pROMOTERLESS VECTORS
    4. lentiviral fusion tags
    5. otherS
  9. Global lentiviral vector market, By type
    1. overview
    2. product
      1. Human immunodeficiency virus (hiv)
      2. FELINE immunodeficiency virus (Fiv)
      3. EQUINE INFECTIOUS ANEMIA virus (eiav)
    3. services
  10. Global lentiviral vector market, By GENERATION
    1. overview
    2. 4th generation
    3. 3rd generation
    4. 2nd generation
    5. 1st generation
  11. Global lentiviral vector market, By workflow
    1. overview
    2. upstream processing
      1. vector amplification & expansion
      2. vector recovery/ harvesting
    3. downstream processing
      1. purification
      2. fill-finish
  12. Global lentiviral vector market, By delivery method
    1. overview
    2. in-vivo
    3. ex-vivo
  13. Global lentiviral vector market, By disease indication
    1. overview
    2. cancer
    3. genetic disorders
      1. b-thalessemia
      2. x-linked adreno leukodystrophy
      3. metachromatic leukodystrophy
      4. wiskott-aldrich syndrome
      5. others
    4. infectious diseases
      1. HIV
      2. OTHERS
    5. veterinary diseases
    6. others
  14. Global lentiviral vector market, By application
    1. overview
    2. gene therapy
      1. recombinant protein expression
      2. functional assays
      3. in vitro transcription
      4. protein characterization
      5. others
    3. vaccinology
  15. Global lentiviral vector market, By end user
    1. overview
    2. academic/ research institutes
    3. pharmaceutical companies
    4. contract development and manufacturing organizations
    5. biotechnology companies
    6. contract research organizations
  16. GLOBAL Lentiviral Vector MARKET, by REGION
    1. overview
    2. NORTH AMERICA
      1. U.S.
      2. Canada
      3. Mexico
    3. EUROPE
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Netherlands
      7. Switzerland
      8. Russia
      9. Turkey
      10. Rest of Europe
    4. ASIA-PACIFIC
      1. China
      2. Japan
      3. Australia
      4. India
      5. South korea
      6. Singapore
      7. Malaysia
      8. Thailand
      9. Indonesia
      10. Philippines
      11. Rest of Asia-Pacific
    5. MIDDLE EAST AND AFRICA
      1. SOUTH AFRICA
      2. Saudi Arabia
      3. U.A.E.
      4. egypt
      5. Israel
      6. Rest of Middle East And Africa
    6. SOUTH AMERICA
      1. BRAZIL
      2. Argentina
      3. Rest of South America
  17. Global Lentiviral Vector Market: COMPANY landscape
    1. company share analysis: Global
    2. company share analysis: North America
    3. company share analysis: Europe
    4. company share analysis: Asia-Pacific
  18. swot
  19. company profile
    1. Oxford Biomedica
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Merck KGaA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. LONZA
      1. COMPANY SNAPSHOT
      2. RECENT ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Cytiva (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. Applied Biological Materials Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. Batavia Biosciences B.V.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. bluebird bio, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. CELL BIOLABS, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Creative Biolabs
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    11. COBRA BIOLOGICS LIMITED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. FinVector Oy
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    13. FUJIFIM DIOSYNTH BIOTECHNOLOGIES (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
      1. COMPANY SNAPSHOT
      2. RECENT ANALYSIS
      3. SERVICE PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. GENEMEDI
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. ORIGENE TECHNOLOGIES, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. SINO BIOLOGICAL, INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    17. SIRION-Biotech GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. SYSTEM BIOSCIENCES, LLC
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. TAKARA BIO INC.
      1. COMPANY SNAPSHOT
      2. RECENT ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    20. Waisman Biomanufacturing
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  20. questionnaire
  21. related reports

表のリスト

TABLE 1 Thermo Fisher Scientific

TABLE 2 The Regents of the University of Michigan

TABLE 3 Kerafast

TABLE 4 Applied Biological Materials Inc.

TABLE 5 Global lentiviral vector market, By component, 2019-2028 (USD million)

TABLE 6 Global lentiviRUS PACKAGING SYSTEMS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 7 Global lentiviRal promoter IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 8 global lentiviral promoter in Lentiviral vector Market, By component, 2019-2028 (USD million)

TABLE 9 Global lentiviRal FUSION TAGS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 10 Global OTHERS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 11 Global lentiviral vector market, By TYPE, 2019-2028 (USD million)

TABLE 12 Global PRODUCT IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 13 Global product in lentiviral vector market, By TYPE, 2019-2028 (USD million)

TABLE 14 Global SERVICES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 15 Global lentiviral vector market, By generation, 2019-2028 (USD million)

TABLE 16 Global 4TH-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 17 Global 3RD-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 18 Global 2ND-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 19 Global 1ST-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 20 Global lentiviral vector market, By work flow, 2019-2028 (USD million)

TABLE 21 Global UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 22 global upstream processing in Lentiviral vector Market, By method, 2019-2028 (USD million)

TABLE 23 Global DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 24 global downstream processing in Lentiviral vector Market, By method, 2019-2028 (USD million)

TABLE 25 Global lentiviral vector market, By delivery method, 2019-2028 (USD million)

TABLE 26 Global IN-VIVO IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 27 Global EX-VIVO IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 28 Global lentiviral vector market, By disease indication, 2019-2028 (USD million)

TABLE 29 Global CANCER IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 30 Global GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 31 global genetic disorders in Lentiviral vector Market, By disease, 2019-2028 (USD million)

TABLE 32 Global INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 33 global infectious diseases in Lentiviral vector Market, By disease, 2019-2028 (USD million)

TABLE 34 Global VETERINARY DISEASES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 35 Global others IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 36 Global lentiviral vector market, By application, 2019-2028 (USD million)

TABLE 37 Global GENE THERAPY IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 38 global gene therapy in Lentiviral vector Market, By application, 2019-2028 (USD million)

TABLE 39 Global VACCINOLOGY IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 40 Global lentiviral vector market, By end user, 2019-2028 (USD million)

TABLE 41 Global ACADEMIC/ RESEARCH INSTITUTES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 42 Global pharmaceutical companies IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 43 Global CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 44 Global BIOTECHNOLOGY COMPANIES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 45 Global CONTRACT RESEARCH ORGANIZATIONS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)

TABLE 46 GLOBAL LENTIVIRAL VECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA Lentiviral Vector Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 48 North America Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 49 North America Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 50 North America Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 51 North America Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 52 North America Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 53 North America Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 54 North America Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 55 North America Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 56 North America Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 57 North America Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 58 North America Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 59 North America Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 60 North America Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 61 North America Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 62 North America Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 63 U.S. Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 64 U.S. Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 65 U.S. Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 66 U.S. Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 67 U.S. Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 68 U.S. Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 69 U.S. Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 70 U.S. Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 71 U.S. Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 72 U.S. Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 73 U.S. Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 74 U.S. Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 75 U.S. Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 76 U.S. Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 77 U.S. Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 78 Canada Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 79 Canada Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 80 Canada Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 81 Canada Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 82 Canada Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 83 Canada Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 84 Canada Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 85 Canada Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 86 Canada Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 87 Canada Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 88 Canada Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 89 Canada Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 90 Canada Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 91 Canada Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 92 Canada Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 93 Mexico Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 94 Mexico Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 95 Mexico Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 96 Mexico Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 97 Mexico Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 98 Mexico Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 99 Mexico Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 100 Mexico Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 101 Mexico Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 102 Mexico Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 103 Mexico Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 104 Mexico Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 105 Mexico Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 106 Mexico Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 107 Mexico Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 108 EUROPE Lentiviral Vector Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 109 Europe Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 110 Europe Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 111 Europe Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 112 Europe Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 113 Europe Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 114 Europe Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 115 Europe Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 116 Europe Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 117 Europe Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 118 Europe Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 119 Europe Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 120 Europe Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 121 Europe Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 122 Europe Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 123 Europe Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 124 U.K. Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 125 U.K. Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 126 U.K. Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 127 U.K. Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 128 U.K. Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 129 U.K. Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 130 U.K. Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 131 U.K. Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 132 U.K. Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 133 U.K. Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 134 U.K. Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 135 U.K. Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 136 U.K. Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 137 U.K. Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 138 U.K. Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 139 Germany Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 140 Germany Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 141 Germany Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 142 Germany Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 143 Germany Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 144 Germany Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 145 Germany Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 146 Germany Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 147 Germany Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 148 Germany Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 149 Germany Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 150 Germany Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 151 Germany Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 152 Germany Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 153 Germany Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 154 France Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 155 France Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 156 France Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 157 France Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 158 France Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 159 France Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 160 France Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 161 France Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 162 France Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 163 France Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 164 France Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 165 France Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 166 France Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 167 France Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 168 France Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 169 Italy Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 170 Italy Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 171 Italy Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 172 Italy Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 173 Italy Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 174 Italy Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 175 Italy Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 176 Italy Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 177 Italy Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 178 Italy Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 179 Italy Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 180 Italy Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 181 Italy Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 182 Italy Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 183 Italy Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 184 Spain Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 185 Spain Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 186 Spain Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 187 Spain Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 188 Spain Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 189 Spain Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 190 Spain Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 191 Spain Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 192 Spain Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 193 Spain Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 194 Spain Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 195 Spain Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 196 Spain Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 197 Spain Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 198 Spain Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 199 Netherlands Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 200 Netherlands Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 201 Netherlands Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 202 Netherlands Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 203 Netherlands Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 204 Netherlands Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 205 Netherlands Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 206 Netherlands Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 207 Netherlands Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 208 Netherlands Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 209 Netherlands Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 210 Netherlands Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 211 Netherlands Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 212 Netherlands Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 213 Netherlands Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 214 Switzerland Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 215 Switzerland Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 216 Switzerland Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 217 Switzerland Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 218 Switzerland Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 219 Switzerland Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 220 Switzerland Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 221 Switzerland Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 222 Switzerland Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 223 Switzerland Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 224 Switzerland Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 225 Switzerland Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 226 Switzerland Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 227 Switzerland Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 228 Switzerland Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 229 Russia Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 230 Russia Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 231 Russia Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 232 Russia Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 233 Russia Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 234 Russia Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 235 Russia Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 236 Russia Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 237 Russia Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 238 Russia Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 239 Russia Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 240 Russia Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 241 Russia Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 242 Russia Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 243 Russia Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 244 TURKEY Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 245 TURKEY Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 246 TURKEY Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 247 TURKEY Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 248 TURKEY Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 249 TURKEY Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 250 TURKEY Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 251 TURKEY Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 252 TURKEY Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 253 TURKEY Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 254 TURKEY Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 255 TURKEY Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 256 TURKEY Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 257 TURKEY Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 258 TURKEY Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 259 Rest of Europe Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 260 ASIA-PACIFIC Lentiviral Vector Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 261 Asia-Pacific Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 262 Asia-Pacific Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 263 Asia-Pacific Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 264 Asia-Pacific Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 265 Asia-Pacific Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 266 Asia-Pacific Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 267 Asia-Pacific Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 268 Asia-Pacific Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 269 Asia-Pacific Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 270 Asia-Pacific Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 271 Asia-Pacific Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 272 Asia-Pacific Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 273 Asia-Pacific Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 274 Asia-Pacific Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 275 Asia-Pacific Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 276 China Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 277 China Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 278 China Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 279 China Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 280 China Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 281 China Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 282 China Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 283 China Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 284 China Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 285 China Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 286 China Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 287 China Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 288 China Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 289 China Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 290 China Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 291 Japan Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 292 Japan Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 293 Japan Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 294 Japan Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 295 Japan Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 296 Japan Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 297 Japan Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 298 Japan Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 299 Japan Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 300 Japan Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 301 Japan Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 302 Japan Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 303 Japan Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 304 Japan Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 305 Japan Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 306 Australia Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 307 Australia Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 308 Australia Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 309 Australia Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 310 Australia Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 311 Australia Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 312 Australia Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 313 Australia Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 314 Australia Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 315 Australia Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 316 Australia Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 317 Australia Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 318 Australia Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 319 Australia Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 320 Australia Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 321 India Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 322 India Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 323 India Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 324 India Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 325 India Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 326 India Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 327 India Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 328 India Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 329 India Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 330 India Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 331 India Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 332 India Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 333 India Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 334 India Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 335 India Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 336 South Korea Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 337 South Korea Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 338 South Korea Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 339 South Korea Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 340 South Korea Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 341 South Korea Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 342 South Korea Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 343 South Korea Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 344 South Korea Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 345 South Korea Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 346 South Korea Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 347 South Korea Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 348 South Korea Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 349 South Korea Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 350 South Korea Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 351 Singapore Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 352 Singapore Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 353 Singapore Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 354 Singapore Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 355 Singapore Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 356 Singapore Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 357 Singapore Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 358 Singapore Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 359 Singapore Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 360 Singapore Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 361 Singapore Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 362 Singapore Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 363 Singapore Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 364 Singapore Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 365 Singapore Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 366 Malaysia Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 367 Malaysia Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 368 Malaysia Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 369 Malaysia Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 370 Malaysia Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 371 Malaysia Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 372 Malaysia Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 373 Malaysia Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 374 Malaysia Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 375 Malaysia Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 376 Malaysia Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 377 Malaysia Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 378 Malaysia Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 379 Malaysia Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 380 Malaysia Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 381 Thailand Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 382 Thailand Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 383 Thailand Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 384 Thailand Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 385 Thailand Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 386 Thailand Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 387 Thailand Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 388 Thailand Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 389 Thailand Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 390 Thailand Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 391 Thailand Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 392 Thailand Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 393 Thailand Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 394 Thailand Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 395 Thailand Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 396 Indonesia Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 397 Indonesia Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 398 Indonesia Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 399 Indonesia Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 400 Indonesia Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 401 Indonesia Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 402 Indonesia Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 403 Indonesia Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 404 Indonesia Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 405 Indonesia Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 406 Indonesia Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 407 Indonesia Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 408 Indonesia Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 409 Indonesia Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 410 Indonesia Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 411 Philippines Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 412 Philippines Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 413 Philippines Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 414 Philippines Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 415 Philippines Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 416 Philippines Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 417 Philippines Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 418 Philippines Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 419 Philippines Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 420 Philippines Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 421 Philippines Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 422 Philippines Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 423 Philippines Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 424 Philippines Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 425 Philippines Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 426 Rest of Asia-Pacific Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 427 MIDDLE EAST AND AFRICA Lentiviral Vector Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 428 Middle East And Africa Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 429 Middle East And Africa Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 430 Middle East And Africa Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 431 Middle East And Africa Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 432 Middle East And Africa Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 433 Middle East And Africa Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 434 Middle East And Africa Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 435 Middle East And Africa Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 436 Middle East And Africa Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 437 Middle East And Africa Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 438 Middle East And Africa Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 439 Middle East And Africa Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 440 Middle East And Africa Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 441 Middle East And Africa Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 442 Middle East And Africa Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 443 SOUTH AFRICA Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 444 SOUTH AFRICA Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 445 SOUTH AFRICA Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 446 SOUTH AFRICA Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 447 SOUTH AFRICA Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 448 SOUTH AFRICA Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 449 SOUTH AFRICA Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 450 SOUTH AFRICA Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 451 SOUTH AFRICA Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 452 SOUTH AFRICA Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 453 SOUTH AFRICA Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 454 SOUTH AFRICA Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 455 SOUTH AFRICA Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 456 SOUTH AFRICA Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 457 SOUTH AFRICA Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 458 Saudi Arabia Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 459 Saudi Arabia Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 460 Saudi Arabia Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 461 Saudi Arabia Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 462 Saudi Arabia Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 463 Saudi Arabia Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 464 Saudi Arabia Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 465 Saudi Arabia Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 466 Saudi Arabia Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 467 Saudi Arabia Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 468 Saudi Arabia Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 469 Saudi Arabia Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 470 Saudi Arabia Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 471 Saudi Arabia Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 472 Saudi Arabia Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 473 U.A.E. Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 474 U.A.E. Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 475 U.A.E. Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 476 U.A.E. Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 477 U.A.E. Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 478 U.A.E. Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 479 U.A.E. Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 480 U.A.E. Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 481 U.A.E. Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 482 U.A.E. Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 483 U.A.E. Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 484 U.A.E. Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 485 U.A.E. Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 486 U.A.E. Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 487 U.A.E. Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 488 Egypt Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 489 Egypt Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 490 Egypt Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 491 Egypt Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 492 Egypt Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 493 Egypt Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 494 Egypt Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 495 Egypt Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 496 Egypt Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 497 Egypt Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 498 Egypt Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 499 Egypt Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 500 Egypt Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 501 Egypt Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 502 Egypt Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 503 Israel Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 504 Israel Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 505 Israel Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 506 Israel Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 507 Israel Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 508 Israel Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 509 Israel Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 510 Israel Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 511 Israel Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 512 Israel Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 513 Israel Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 514 Israel Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 515 Israel Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 516 Israel Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 517 Israel Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 518 Rest of Middle East And Africa Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 519 SOUTH AMERICA Lentiviral Vector Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 520 South America Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 521 South America Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 522 South America Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 523 South America Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 524 South America Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 525 South America Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 526 South America Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 527 South America Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 528 South America Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 529 South America Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 530 South America Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 531 South America Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 532 South America Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 533 South America Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 534 South America Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 535 BRAZIL Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 536 BRAZIL Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 537 BRAZIL Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 538 BRAZIL Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 539 BRAZIL Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 540 BRAZIL Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 541 BRAZIL Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 542 BRAZIL Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 543 BRAZIL Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 544 BRAZIL Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 545 BRAZIL Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 546 BRAZIL Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 547 BRAZIL Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 548 BRAZIL Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 549 BRAZIL Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 550 Argentina Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 551 Argentina Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

TABLE 552 Argentina Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 553 Argentina Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)

TABLE 554 Argentina Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)

TABLE 555 Argentina Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)

TABLE 556 Argentina Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 557 Argentina Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)

TABLE 558 Argentina Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 559 Argentina Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 560 Argentina Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 561 Argentina Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)

TABLE 562 Argentina Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 563 Argentina Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)

TABLE 564 Argentina Lentiviral Vector Market, By End User, 2019-2028 (USD Million)

TABLE 565 Rest of South America Lentiviral Vector Market, By Component, 2019-2028 (USD Million)

図表一覧

FIGURE 1 Global LENTIVIRAL VECTOR MARKET: SEGMENTATION

FIGURE 2 GLOBAL LENTIVIRAL VECTOR MARKET: DATA TRIANGULATION

FIGURE 3 global Lentiviral vector market: DROC ANALYSIS

FIGURE 4 Global Lentiviral vector market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global Lentiviral vector market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Lentiviral vector market: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Lentiviral vector market: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL LENTIVIRAL VECTOR MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL LENTIVIRAL VECTOR MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL lentiviral vector market: MARKET application COVERAGE GRID

FIGURE 11 Global Lentiviral vector market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Lentiviral vector market AND europe IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 growing geriatric population is expected to DRIVe THE global Lentiviral vector market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 lentivirus packaging systems SEGMENT is expected to account for the largest share of the global LENTIVIRAL VECTOR MARKET in 2021 & 2028

FIGURE 15 EUROPE is the fastest growing market FOR the Lentiviral vector MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF global lentiviral vector market

FIGURE 17 Global lentiviral vector market: By component, 2020

FIGURE 18 Global lentiviral vector market: By component, 2019-2028 (USD million)

FIGURE 19 Global lentiviral vector market: By component, CAGR (2021-2028)

FIGURE 20 Global lentiviral vector market: By component, LIFELINE CURVE

FIGURE 21 Global lentiviral vector market: By TYPE, 2020

FIGURE 22 Global lentiviral vector market: By TYPE, 2019-2028 (USD million)

FIGURE 23 Global lentiviral vector market: By TYPE, CAGR (2021-2028)

FIGURE 24 Global lentiviral vector market: By TYPE, LIFELINE CURVE

FIGURE 25 Global lentiviral vector market: By generation, 2020

FIGURE 26 Global lentiviral vector market: By generation, 2019-2028 (USD million)

FIGURE 27 Global lentiviral vector market: By generation, CAGR (2021-2028)

FIGURE 28 Global lentiviral vector market: By generation, LIFELINE CURVE

FIGURE 29 Global lentiviral vector market: By work flow, 2020

FIGURE 30 Global lentiviral vector market: By work flow, 2019-2028 (USD million)

FIGURE 31 Global lentiviral vector market: By work flow, CAGR (2021-2028)

FIGURE 32 Global lentiviral vector market: By work flow, LIFELINE CURVE

FIGURE 33 Global lentiviral vector market: By delivery method, 2020

FIGURE 34 Global lentiviral vector market: By delivery method, 2019-2028 (USD million)

FIGURE 35 Global lentiviral vector market: By delivery method, CAGR (2021-2028)

FIGURE 36 Global lentiviral vector market: By delivery method, LIFELINE CURVE

FIGURE 37 Global lentiviral vector market: By disease indication, 2020

FIGURE 38 Global lentiviral vector market: By disease indication, 2019-2028 (USD million)

FIGURE 39 Global lentiviral vector market: By disease indication, CAGR (2021-2028)

FIGURE 40 Global lentiviral vector market: By disease indication, LIFELINE CURVE

FIGURE 41 Global lentiviral vector market: By application, 2020

FIGURE 42 Global lentiviral vector market: By application, 2019-2028 (USD million)

FIGURE 43 Global lentiviral vector market: By application, CAGR (2021-2028)

FIGURE 44 Global lentiviral vector market: By application, LIFELINE CURVE

FIGURE 45 Global lentiviral vector market: By end user, 2020

FIGURE 46 Global lentiviral vector market: By end user, 2019-2028 (USD million)

FIGURE 47 Global lentiviral vector market: By end user, CAGR (2021-2028)

FIGURE 48 Global lentiviral vector market: By end user, LIFELINE CURVE

FIGURE 49 GLOBAL Lentiviral Vector MARKET: SNAPSHOT (2020)

FIGURE 50 GLOBAL Lentiviral Vector MARKET: BY Region (2020)

FIGURE 51 GLOBAL Lentiviral Vector MARKET: BY Region (2021 & 2028)

FIGURE 52 GLOBAL Lentiviral Vector MARKET: BY Region (2020 & 2028)

FIGURE 53 GLOBAL Lentiviral Vector MARKET: BY COMPONENT (2021-2028)

FIGURE 54 NORTH AMERICA Lentiviral Vector MARKET: SNAPSHOT (2020)

FIGURE 55 NORTH AMERICA Lentiviral Vector MARKET: BY COUNTRY (2020)

FIGURE 56 NORTH AMERICA Lentiviral Vector MARKET: BY COUNTRY (2021 & 2028)

FIGURE 57 NORTH AMERICA Lentiviral Vector MARKET: BY COUNTRY (2020 & 2028)

FIGURE 58 NORTH AMERICA Lentiviral Vector MARKET: BY COMPONENT (2021-2028)

FIGURE 59 EUROPE Lentiviral Vector MARKET: SNAPSHOT (2020)

FIGURE 60 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2020)

FIGURE 61 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2021 & 2028)

FIGURE 62 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2020 & 2028)

FIGURE 63 EUROPE Lentiviral Vector MARKET: BY COMPONENT (2021-2028)

FIGURE 64 ASIA-PACIFIC Lentiviral Vector MARKET: SNAPSHOT (2020)

FIGURE 65 ASIA-PACIFIC Lentiviral Vector MARKET: BY COUNTRY (2020)

FIGURE 66 ASIA-PACIFIC Lentiviral Vector MARKET: BY COUNTRY (2021 & 2028)

FIGURE 67 ASIA-PACIFIC Lentiviral Vector MARKET: BY COUNTRY (2020 & 2028)

FIGURE 68 ASIA-PACIFIC Lentiviral Vector MARKET: BY COMPONENT (2021-2028)

FIGURE 69 MIDDLE EAST AND AFRICA Lentiviral Vector MARKET: SNAPSHOT (2020)

FIGURE 70 MIDDLE EAST AND AFRICA Lentiviral Vector MARKET: BY COUNTRY (2020)

FIGURE 71 MIDDLE EAST AND AFRICA Lentiviral Vector MARKET: BY COUNTRY (2021 & 2028)

FIGURE 72 MIDDLE EAST AND AFRICA Lentiviral Vector MARKET: BY COUNTRY (2020 & 2028)

FIGURE 73 MIDDLE EAST AND AFRICA Lentiviral Vector MARKET: BY COMPONENT (2021-2028)

FIGURE 74 SOUTH AMERICA Lentiviral Vector MARKET: SNAPSHOT (2020)

FIGURE 75 SOUTH AMERICA Lentiviral Vector MARKET: BY COUNTRY (2020)

FIGURE 76 SOUTH AMERICA Lentiviral Vector MARKET: BY COUNTRY (2021 & 2028)

FIGURE 77 SOUTH AMERICA Lentiviral Vector MARKET: BY COUNTRY (2020 & 2028)

FIGURE 78 SOUTH AMERICA Lentiviral Vector MARKET: BY COMPONENT (2021-2028)

FIGURE 79 Global Lentiviral Vector Market: company share 2020 (%)

FIGURE 80 North America Lentiviral Vector Market: company share 2020 (%)

FIGURE 81 Europe Lentiviral Vector Market: company share 2020 (%)

FIGURE 82 Asia-Pacific Lentiviral Vector Market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The Lentiviral Vector Market size will be worth USD 25.32 million by 2030
The Growth Rate of Lentiviral Vector Market is 11.9% by 2030
Increasing agreements and collaborations and Increasing research and development activities are the Growth Drivers of the Lentiviral Vector Market
The major companies Cobra Biologics Limited (U.K.), Sirion-Biotech GmbH (Germany), Merck KGaA (Germany), FinVector Oy (Finland), Oxford Biomedica (U.K.), OriGene Technologies, Inc. (U.S.), Sino Biological Inc. (China), Cell Biolabs, Inc. (U.S.), Batavia Biosciences B.V. (Netherlands), Lonza (Switzerland), GENEMEDI (China), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Waisman Biomanufacturing (U.S.), and Cytiva (U.S.)
Component, type, generation, workflow, delivery method, disease indication, application and end user are the factors on which the Lentiviral Vector Market research is based

関連ページを閲覧する

Banner